Presage Biosciences Receives $3,100,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7293e6ba-d13a-4629-a833-4966b9748c92&Preview=1
Date
3/16/2010
Company Name
Presage Biosciences
Mailing Address
Undisclosed Seattle, WA 98101
Company Description
Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors. Frustrated by a lack of tools to identify pre-existing resistance to oncology drugs in his patients, Dr. Olson’s team developed a strategy to assess tumor responses to drug treatments empirically, before subjecting patients to a treatment cycle, frequently with side effects. Presage is using Dr. Olson’s invention to improve the lives of cancer patients though drug development applications.
Website
http://www.presagebio.com
Transaction Type
Venture Equity
Transaction Amount
$3,100,000
Transaction Round
Undisclosed
Proceeds Purposes
The idea at Presage is to radically improve the odds that cancer drug candidates will successfully navigate through clinical trials.
M&A Terms
Venture Investor
Undisclosed